SCHEMBL27933

SCHEMBL27933

CCC(Br)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23581065 1.00
SCHEMBL31296255 0.74
SCHEMBL31296248 0.74
SCHEMBL906274 0.74
SCHEMBL23803919 0.73
SCHEMBL3950307 0.73
SCHEMBL9475298 0.71
SCHEMBL4293677 0.69
SCHEMBL3942924 0.69
SCHEMBL9452480 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4610251-A1 HEPTAFLUOROISOPROPYL-CONTAINING BISAMIDE COMPOUND AND INTERMEDIATE COMPOUND THEREOF, AND PREPARATION METHODS THEREFOR AND USE THEREOF Zhejiang Udragon Pesticides And Chemicals Co., Ltd. (CN) 2025-09-03 EP claimed
CN-118684679-A Phthalocyanine compound, acidic substance alarm system and application 兰州大学 2024-09-24 CN claimed
EP-4062479-A1 FLAME RETARDANTS FOR BATTERY ELECTROLYTES ALBEMARLE CORPORATION (US) 2022-09-28 EP claimed
WO-2021101922-A1 FLAME RETARDANTS FOR BATTERY ELECTROLYTES ALBEMARLE CORPORATION (US) 2021-05-27 WO claimed
WO-2013171767-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF ALISKIREN MYLAN LABORATORIES LIMITED (IN) 2013-11-21 WO claimed
EP-2303856-A2 PROCESS FOR THE PREPARATION OF 3,4-DIHYDRO-2H-THIEN[3,2-E]-1,2-THIAZIN-4-OL 1, 1-DIOXIDE DERIVATIVES AND INTERMEDIATES PHF SA (CH) 2011-04-06 EP claimed
WO-2010103550-A2 PROCESS FOR THE PREPARATION OF INTERMEDIATES INDOCO REMEDIES LIMITED (IN) 2010-09-16 WO claimed
WO-2010004457-A2 PROCESS FOR THE PREPARATION OF BRINZOLAMIDE PHF SA (CH) 2010-01-14 WO claimed
EP-2079749-A2 IMPROVED PROCESS FOR THE PREPARATION OF (R)-(+)-4-(ETHYIAMINO)-3,4-DIHYDRO-2-(3- METHOXYPROPYL)-2H-THIENO[3,2-E]-L,2-THIAZINE-6-SULFONAMIDE-L,L-DIOXIDE USV LIMITED (IN) 2009-07-22 EP claimed
WO-2008062463-A2 IMPROVED PROCESS FOR THE PREPARATION OF (R)-(+)-4-(ETHYIAMINO)-3,4-DIHYDRO-2-(3- METHOXYPROPYL)-2H-THIENO[3,2-E]-L,2-THIAZINE-6-SULFONAMIDE-L,L-DIOXIDE USV LIMITED (IN) 2008-05-29 WO claimed
WO-1996010573-A1 ENANTIOSELECTIVE SYNTHESIS OF SULFONAMIDE INTERMEDIATES ALCON LABORATORIES, INC. (US) 1996-04-11 WO claimed
EP-4610251-A1 HEPTAFLUOROISOPROPYL-CONTAINING BISAMIDE COMPOUND AND INTERMEDIATE COMPOUND THEREOF, AND PREPARATION METHODS THEREFOR AND USE THEREOF Zhejiang Udragon Pesticides And Chemicals Co., Ltd. (CN) 2025-09-03 EP disclosed
EP-4598536-A2 INDAZOLE PYRIDONE COMPOUNDS AND USES THEREOF Bluejay Therapeutics, Inc. (US) 2025-08-13 EP disclosed
EP-4561585-A1 IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION Sanifit Therapeutics S.A. (ES) 2025-06-04 EP disclosed
CN-115974717-B Bisamide compound containing sevoflurane isopropyl and intermediate compound thereof, preparation method and application thereof 浙江宇龙药业有限公司 2025-03-14 CN disclosed
EP-0678503-A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed
WO-1995017409-A1 DIPHOSPHINE DIOXIDES FOR REMOVING ACTINIDES AND PHOSPHONIUM DISALTS FOR PREPARING SAME COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1995-06-29 WO disclosed
US-5334591-A Useful in the treatment of ocular hypertension and glaucoma MERCK & CO., INC. (US) 1994-08-02 US disclosed
EP-0543497-A1 Tricyclic thienothiopyrans as antiglancoma agents MERCK & CO. INC. (US) 1993-05-26 EP disclosed
US-5175284-A Glaucoma MERCK & CO., INC. (US) 1992-12-29 US disclosed